It was demonstrated that lysophospholipid species such as lysophosphatidylethanolamine (LPE), lysophosphatidylcholine (LPC) and lysophosphatidylserine (LPS) are influenced by wild-type p53 in pancreatic cancer [19]. This evidence concerns the gene TP53 and familial pancreatic carcinoma.